Who owns VIVOS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Vivos Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Vivos Therapeutics stock

Who bought or sold VIVOS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 304k $617k 233% Dec 2025
 View chart
DRW Holdings 116k $235k 180% Dec 2025
 View chart
Geode Capital Management 56k $114k 6% Dec 2025
 View chart
National Asset Management 44k $135k -37% Sep 2025
 View chart
Commonwealth Equity Services 41k $82k -1% Dec 2025
 View chart
BlackRock 28k $57k 0% Dec 2025
 View chart
State Street Corporation 25k $51k 0% Dec 2025
 View chart
Acorn Wealth Advisors 15k $30k 100% Dec 2025
 View chart
UBS Group 13k $26k 12328% Dec 2025
 View chart
Northern Trust 13k $25k 0% Dec 2025
 View chart
Tower Research Capital 3.0k $6.0k 6% Dec 2025
 View chart
Advisor Group Holdings 1.1k $2.3k -83% Dec 2025
 View chart
Signature 547.00 $1.1k 0% Dec 2025
 View chart
Ronald Blue Trust 160.00 $324.992000 0% Dec 2025
 View chart
Kozak & Associates 49.00 $100.998800 0% Dec 2025
 View chart
FMR 40.00 $124.000000 100% Sep 2025
 View chart
Royal Bank of Canada 4.00 $0 0% Sep 2025
 View chart

Who sold out of Vivos Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Connective Capital Management Sep 2025 200k $620k
Strategic Wealth Designers Sep 2025 100k $310k
Renaissance Technologies Sep 2025 39k $122k
Global Retirement Partners Sep 2025 23.00 $71.001000